Kim will participate in an NIH funded project entitled “Combined Nanoparticle and Neural Stem Cell Therapies in a Pig Model of Stroke (1R01NS093314-01A1)”. As part of the research team, Kim will be involved in assessing nanoparticle efficacy utilizing histological endpoints in a stroke pig model. Histologically, she will assess the effect of nanoparticles delivering the anti-oxidant coQ10 and the anti-inflammatory tetracycline on neuron survival, gliosis, macrophage infiltration, activation of endogenous neural stem cells and lesion size. Congratulations, Kim!

Posted in: